MedTrace Logo

Effectiveness of Cervical Screening in HPV Vaccinated Women

NCT02149030 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6958

Last updated 2025-01-20

No results posted yet for this study

Summary

The main objective of the study is to identify whether or not being informed infrequently results about screening is: 1) At least as safe and accurate as frequently obtaining all information from the present combination of opportunistic/organized cervical screening by comparing regimen results of three screening visits at the ages of 22, 25 and 30 years (Arm A1) vs. results of one screening visit at the age of 30 years (Arm A2) in Human papillomavirus (HPV) vaccinated young women.

Conditions

  • Cervical Intraepithelial Neoplasia Grade 2/3

Interventions

OTHER

Cytological screening in A1 and A3

Cytological screening.

Sponsors & Collaborators

  • European Union

    collaborator OTHER

  • Academy of Finland

    collaborator OTHER

  • Cancer Society of Finland

    collaborator UNKNOWN

  • Tampere University

    lead OTHER

Principal Investigators

  • Matti Lehtinen, MD, PhD · Tampere University

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Max Age
22 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2025-01-31
Completion
2025-01-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02149030 on ClinicalTrials.gov